Protocol Page


	Study ID (Protocol Number)
	CA180-372


	STUDY LOCATIONS*
	A. I. Dupont Hospital For Children Wilmington, DE 19803 Recruiting	Antranik Agop Bedros Loma Linda, CA 92350 Recruiting
	All Children's Hospital St. Petersburg, FL 33701 Recruiting	Baylor College Of Med/Tx Chldrns Cancer & Hem Ctrs. Houston, TX 77030 Recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
	STUDY OVERVIEW
	The purpose of this study is to determine whether Dasatinib when added to standard chemotherapy is effective and safe in the treatment of pediatric philadelphia chromosome positive acute lymphoblastic leukemia

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.